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Abstract
Proteins and RNA are often found in ribonucleoprotein particles (RNPs), where
they function in cellular processes to synthesize proteins (the ribosome),
chemically modify RNAs (small nucleolar RNPs), splice pre-mRNAs (the
spliceosome), and, on a larger scale, sequester RNAs, degrade them, or
process them (P bodies, Cajal bodies, and nucleoli). Each RNA–protein
interaction is a story in itself, as both molecules can change conformation,
compete for binding sites, and regulate cellular functions. Recent studies of Xist
long non-coding RNP, the U4/5/6 tri-small nuclear RNP complex, and an
activated state of a spliceosome reveal new features of RNA interactions with
proteins, and, although their stories are incomplete, they are already
fascinating.
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Introduction
RNA molecules in the cell are rarely naked. Rather, proteins are 
bound to them in some arrangement consistent with their regula-
tion, protection from nucleases, transport, or formation of ribonu-
cleoprotein particles (RNPs). A 2014 compendium of RNA-binding 
proteins in humans1 concluded that 7.5% of 20,500 known protein-
coding genes are found in RNPs or bound to mRNAs, where they 
regulate RNA metabolism. This is likely to be an underestimate, 
since their structural heterogeneity makes them difficult to identify 
de novo.
The recent discovery of a plethora of non-coding RNAs2 in 
cells has invigorated investigation of proteins that bind to RNA. 
New methods of probing the proteins in a transcriptome have 
allowed simultaneous identification of a protein and its RNA- 
binding site. Typically, these are crosslinking-immunoprecipita-
tion (CLIP) experiments3–9. Intact cells can be irradiated with 
ultraviolet (UV) light or treated with formaldehyde to crosslink 
proteins to RNA, then the complexes are purified from the milieu 
by immunoprecipitation. To identify proteins bound to mRNAs, 
cellular UV RNA–protein crosslinking is followed by isolation 
of all poly(A)-RNA7. Alternatively, proteins bound to a specific 
RNA could be recovered by annealing biotin-oligonucleotides 
complementary to the RNA and selective purification by 
streptavidin9. Proteins bound to RNAs could then be identified 
by mass spectrometry. Several groups applied this method to 
identify mRNA-binding proteins in human cell lines, mouse 
embryonic stem cells (ESCs), and Saccharomyces cerevisiae yeast 
cells (reviewed in Gerstberger et al.1).
Assuming that there are indeed more than 1,500 RNA-binding 
proteins in human cells, books will be written about them and 
their roles in RNA biology. Here, I focus on recent advances that 
reveal the variety and mystery of RNPs.
Xist, the RNA that inactivates an X chromosome
Xist is a long non-coding RNA (lncRNA) that is responsible for 
transcriptional silencing of one of two X chromosomes in female 
cells10–13. There are approximately 200 Xist molecules bound 
to a single X chromosome, and each 18 kb of Xist is bound by 
proteins (Figure 1). Proteins could participate in any aspect of its 
biology: Xist has to associate with the X chromosome, then spread 
along it, and finally inhibit RNA polymerase II (Pol II) transcrip-
tion. After more than twenty years of efforts to identify those pro-
teins, the power of mass spectroscopy has been applied to proteins 
crosslinked in cellulo to Xist.
Two research groups have recently published compendia of 
Xist-bound proteins. Each group first crosslinked RNA to protein 
in cellulo, selected Xist through oligonucleotide-directed anneal-
ing, then used quantitative mass spectrometry to identify bound 
proteins. An overall comparison of their results shows great simi-
larity but also some curious and intriguing differences. Table 1 
and Table 2 list the most abundant proteins recovered from each 
study.
The groups of Heard and Chang14 identified 81 proteins in toto 
bound to Xist. Using formaldehyde, they crosslinked proteins to 
Xist in three different mouse cell types: a male ESC line containing 
Figure 1. Xist wraps around nucleosomes in the X chromosome. 
Approximately 200 Xist molecules bind to an X chromosome, spread 
along it, and inhibit RNA polymerase II from transcribing the DNA. 
Xist is bound by many proteins at unknown sites and with unknown 
stoichiometry, which subsequently interact with each other through 
disordered regions or structured domains. RNA is shown as a 
yellow/orange strand and protein linkers as blue strands. RRM, RNA 
recognition motif.
Table 1. Top 15 Xist-binding proteins from Chl-MS recovery in 
mouse cells14.
Crosslinked 
proteins
In order of 
abundance
Protein structural 
motifs
Length* 
(number 
of amino 
acids)
hnRNP M 1 3 RRM 728
hnRNP U (Saf-A) 2 RGG, KH, acidic 
region, DNA binding
793
hnRNP K 3 3 KH, proline-rich 463
hnRNP A2/B1 4 2 RRM, RGG, 
glycine-rich
353
MYEF2 5 2 non-canonical 
RRMs, homology to 
hnRNP M4
591
hnRNP A1 6 2 RRM, glycine-rich, 
RGG
320
DDX5 7 DEAD box protein
Spen (SHARP) 8 3 RRM, SPOC 3,640
RBM XL1 9 RRM
hnRNP AB 10 2 RRM
hnRNP D (AUF1) 11 2 RRM 355
hnRNP L 12 4 RRM, glycine-rich 589
hnRNP A3 13 2 RRM, glycine-rich 379
hnRNP C 14 1 RRM, acid rich 293
TARDBP (TDP-43) 15 2 RRM, glycine-rich, 
DNA-binding protein
414
*Many proteins have isoforms with varying lengths; the longest variant in 
Homo sapiens is listed.
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an inducible Xist gene, an epiblast stem cell line, and trophoblast 
stem cells. Each cell type represents one stage of Xist expression. 
Combining all datasets, three proteins were identified as being 
most abundant: heterogeneous nuclear RNP (hnRNP) K, hnRNP 
U, and hnRNP M. In addition, a detailed examination of Xist 
5′ 0.9 kb sequence revealed several localized proteins. In particular, 
SPEN (aka SHARP) was found to be necessary for transcriptional 
silencing.
There is a preponderance of hnRNP proteins. These heterogene-
ous nuclear ribonucleoproteins are abundant in metazoan cells, 
where they are mostly found in the nucleus15,16. A recent review of 
them traced their ancestry17, concluding that there are 13 families, 
each with isoforms or variants. For example, hnRNP A has four 
homologues in humans (A0, A1, A2, and A3), while hnRNP M has 
two (MYEF2 and hnRNP M). These proteins typically use RNA 
recognition motifs (RRMs) to bind RNA, while their other domains 
engage in protein–protein interactions. Several are involved in 
pre-mRNA splicing, where they repress splice site selection 
(hnRNP A18) or regulate exon inclusion (hnRNP I19). hnRNP I (aka 
polypyrimidine tract binding protein 1 [PTB1]) also facilitates 
translation from internal ribosome entry sites (IRES)20,21. hnRNP 
functions in Xist are unknown, with the exception of hnRNP U (aka 
Saf-A), which facilitates Xist localization on chromatin22.
In contrast, a group of investigators headed by Guttman23 took 
a different approach to finding Xist proteins during transcrip-
tional silencing. After Xist induction in mouse ESCs, cells were 
UV-crosslinked, Xist RNP was recovered with long antisense 
oligonucleotides, and Xist proteins were identified by mass spec-
trometry. Two batches of mouse ESCs were cultured, one in 
15N- and one in 14N-media to allow quantification by mass 
spectrometry (SILAC). Among their ten most abundant proteins, 
they found SHARP (SPEN) and RMD15, two proteins related 
in their architecture (they are SPEN family proteins). They also 
recovered six hnRNP proteins (Table 2).These are exciting 
findings. In a curious coincidence, SHARP has another life in a 
nuclear RNP with the steroid receptor RNA activator (SRA)24. 
SRA is a lncRNA that co-regulates the transcription of nuclear 
receptors24. Bound to SRA, SHARP represses SRA transactivation 
when it recruits histone deacetylate25. Does it carry out a similar 
task in Xist2,10?
In fact, McHugh et al. found that SHARP was required for the 
inhibition of Pol II transcription at sites where Xist was bound23. 
The mechanism of inhibition could lie in the recruitment of 
SMRT and/or HDAC325. HDAC3 is a histone deacetylase26 that 
is thought to be responsible for transcriptional repression by 
changing chromatin structure27. Loss of SHARP, LBR, or 
hnRNP U in knockdown experiments was sufficient to eliminate 
silencing23, but each protein appears to have unique contributions. 
The role of the other seven proteins was not tested directly, but 
since each binds directly to Xist, they could have functions in 
localization, recruitment of other enzymes, stabilization, etc. (for 
example, binding to Polycomb repressive complex 2 [PRC2]).
The identification of LBR bound to Xist explains localization of 
the Xist-X chromosome to the nuclear lamina12. Transmembrane 
helices anchor LBR to the lamina, while its tail contacts Xist. Posi-
tioning of Xist-X on the lamina changes the structure of the DNA 
and facilitates protein-mediated spreading of the Xist molecules 
along the length of the chromatin.
Rather than discovering unknown proteins, these investigations 
have re-discovered known proteins. They present a new challenge: 
to understand why they are particularly useful in the Xist context 
and how their use, and corresponding abundance, is modulated 
according to developmental stage or cell lineage. The general 
challenge is not only to understand how proteins use their RNA- 
binding domains and intervening sequences and disordered tails to 
control formation of RNPs but must also account for their temporal 
exchange.
RNA recognition motifs
A striking feature of proteins bound to Xist is the recurring use 
of tandem RRM domains. There are certainly advantages to this 
scheme, since affinity and specificity can be modulated by increas-
ing the number of contacts between RNA and protein. However, 
neither Xist-binding sites for its associated proteins nor their bind-
ing stoichiometry are known. These biochemical characterizations 
are important to understand how they select their target sites on 
Table 2. Mouse embryonic stem cells: top 10 Xist-binding 
proteins from RAP-MS23.
Crosslinked 
proteins
In order of 
abundance
Protein structural 
motifs
Length 
(number 
of amino 
acids)
SHARP 
(SPEN)
1 3 RRM, SPOC 3,640
RBM15 2 3 RRM, SPOC 969
MYEF2 
(hnRNP M)
3 3 RRMs, homology to 
hnRNP M4
591
CELF1 4 3 RRMs 486
hnRNP C 5 1 RRM 313
LBR 6 Chromatin-interaction 
domain, transmembrane 
region, lamin-interacting 
domain
626
SAF-A 
(hnRNP U)
7 RGG, SPRY domain, 
ATPase domain
793
RALY 
(hnRNP C)
8 1 RRM 312
hnRNP M 9 3 RRM 729
PTBP1 
(hnRNP I)
10 4 RRM 555
hnRNP, heterogeneous nuclear ribonucleoprotein particle; RAP-MS, RNA 
antisense purification-mass spectrometry; RRM, RNA recognition motif; 
SILAC, stable isotope labeling by amino acids in culture; SPOC, Spen 
paralog and ortholog C-terminal domain.
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the RNA, how they bind to Xist in the milieu of other RNAs in the 
cell, and how they hang onto the RNA while they also bind to other 
cellular compartments or recruit other proteins.
RRMs1 are the most common structural motif used in eukaryo-
tes to bind RNA (Figure 2) and are estimated to be found in 
225 human genes. When RRMs are present in multiples, deci-
phering the contributions of each RRM to the whole can be quite 
difficult28–31. A recent biophysical study of two tandem RRMs 
revealed how they partition function.
U2 auxiliary factory (U2AF) is a heterodimer of U2AF65 and 
U2AF3532,33, which in pre-mRNA splicing aids in the recogni-
tion of a 3′ splice site34–38. U2AF65 has two RRMs (RRM1 and 
RRM2) that bind polypyrimidine tracts, but U2AF35 has a single 
UHM, a “U2AF homology motif”, that is structurally homologous 
to an RRM39,40. RRM1 and RRM2 are tethered by a short linker 
(~20 amino acids) that allows them to undergo relative motion and 
orientation36. Since they bind to polypyrimidine tracts of variable 
length and sequence, they must be able to expand or contract to 
span the site41.
The Sattler and Lamb laboratories collaborated on a compre-
hensive study of the spatiotemporal disposition of U2AF65 
RRM1 and RRM2 and their role in RNA binding. von Voithenberg 
et al.35 showed that RRM1 and RRM2 undergo dynamic exchange 
between a closed or open orientation at equilibrium (Figure 2). In 
the closed state, RRM1 and RRM2 do not bind RNA, but when 
the conformation is open, a polypyrimidine tract can bind. If 
binding is weak (i.e. the polypyrimidine tract is too short or con-
tains multiple purine nucleotides), the exchange between open and 
closed states is relatively unperturbed. If RNA binding is tight, 
RRM1 and RRM2 will be trapped in an open state. Thus, the RNA 
shifts the equilibrium of U2AF RRM1 and RRM2 between open 
and closed states in an example of conformational selection.
These experiments were conducted using single pair Förster 
resonance energy transfer (spFRET) that observed single mole-
cules, each containing a donor and acceptor fluorophore. One fluor-
ophore was attached to either RRM, such that the open and closed 
orientations were distinguished by the FRET efficiency. Combin-
ing measurements of fluorophore lifetimes with spFRET facilitated 
temporal characterization of exchange between open and closed 
states. In experimental conditions, free RRM1 and RRM2 occupied 
an open state ~67% of the time. Addition of RNA trapped RRM1 
and RRM2 in the open conformation 90% of the time.
U2AF65 and U2AF35 have been the subject of many biochemi-
cal and structural investigations, since they are essential proteins 
for pre-mRNA splicing. In particular, experimental studies of 
protein–protein interactions between U2AF and other proteins 
have identified sites where interactions occur42–45. These latest 
experiments revealed a mechanism of protein–protein interaction 
involving the UHM of U2AF35 and U2AF65 RRM1 and RRM2. 
A combination of nuclear magnetic resonance (NMR) structure 
and dynamics experiments identified the binding site of U2AF35 
UHM to be a surface of U2AF65 RRM1. Binding of the UHM to 
RRM1 shifts the RRM1 and RRM2 conformational equilibrium 
to the open state, thereby favoring RNA binding. The authors sug-
gest that allostery drives the RRM1 and RRM2 conformational 
switch. Allosteric modulation of binding is a powerful mechanism 
to provide discrimination and affinity46–49, but, by its nature, it is 
almost impossible to anticipate and cannot be gleaned from static 
structures.
Figure 2. Regulation of RNA recognition motif (RRM) binding to RNA. A. An RRM has a four-stranded anti-parallel β-sheet, with two 
α-helices on one side92–95. RNA often sits on the surface of the β-sheet. B. The two RRMs of U2 auxiliary factor (U2AF) exhibit closed/open 
transitions at equilibrium, but only in the open state can RNA bind. Binding of the U2AF homology motif (UHM) from U2AF35 to RRM1 shifts 
the equilibrium to favor the open state, which facilitates RNA binding. The C-terminal tail of U2AF65 contacts the U2AF35 UHM. ESE, exonic 
splicing enhancer.
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Many RNA-binding proteins are modular, with an RNA-binding 
domain, intervening sequences, and disordered tails. Here, U2AF 
uses two proteins to regulate splicing; other examples include the 
Sxl-Unr heterodimer that regulates translation via interactions 
between Sxl RRM and a Unr cold-shock domain50, while the SR 
protein (serine-arginine) SRSF1 is regulated by phosphorylation of 
its RS tail that blocks intramolecular interaction with its RRMs51,52. 
Regulation by intermolecular and intramolecular interactions adds 
another level of complexity to RNA-binding proteins.
The spliceosome and its small nuclear ribonucleoprotein 
particles
It is estimated that 94% of all human genes contain introns53–55, 
thereby providing protein isoform diversity. The process of 
removing introns and joining exons is carried out by the spliceo-
some, a multi-component and dynamic assembly of RNPs56. A 
great challenge in the field of pre-mRNA splicing has been to 
understand how the spliceosome is physically able to carry out the 
concerted transesterification reactions of the splicing chemistry to 
yield mRNAs.
The spliceosome consists of five small nuclear RNPs (snRNPs) that 
dynamically associate with each other and with pre-mRNA. The 
major spliceosome uses U1, U2, U4, U5, and U6 snRNPs in the 
process of splicing57. Each snRNP contains a single RNA (snRNA) 
and multiple proteins, but while U1 and U2 snRNPs are independ-
ent, U4 and U6 form a di-snRNP that goes on to become a U4/U5/
U6 tri-snRNP58. The tri-snRNP is recruited to a bona-fide intron 
and is then remodeled, losing U4 snRNP and leaving U5 and U6 
snRNPs to form the active spliceosome.
The goal of snRNP rearrangement is to allow and facilitate snRNA 
conformational rearrangements in the spliceosome to produce the 
active site for catalysis59–61. Rearrangements of pre-mRNA and 
snRNAs to prepare and position them for catalysis are mainly 
accomplished by protein helicases62. There are eight such type SF2 
helicases that associate with the spliceosome along the reaction 
pathway63,64. These ATP-dependent RNA helicases are not sequence 
specific; they can unwind any RNA duplex. Rather, their specific 
targets appear to be defined by where and when they associate with 
the spliceosome. The Brr2 helicase is particularly critical in the 
transformation of pre-spliceosome intermediates64–67. Brr2 is unu-
sual: it has two helicase domains (only one is active) and a long 
(450-amino-acid) N-terminal domain64,65,68,69.
Brr2, a unique RNA helicase
Brr2 enters the nucleus independently and associates with the 
U5 snRNP. U5 snRNP then joins the U4/U6 di-snRNP to become 
the U4/U5/U6 tri-snRNP68. The tri-snRNP is recruited by U1 and 
U2 snRNPs to form a pre-spliceosome.
To form the active spliceosome, two snRNPs must be displaced. 
U1 snRNP is released from the 5′ splice site, and U4 snRNP is 
removed from the tri-snRNP. It is the latter remodeling that 
requires Brr2, as U4 and U6 snRNAs are joined by 22 perfect 
base pairs and Brr2 is the helicase that separates them. Only when 
U6 snRNA is free of U4 snRNA can it rearrange to base pair with 
U2 snRNA and pre-mRNA and so form the catalytic center of the 
spliceosome. Clearly, Brr2 activity must be regulated such that it is 
inactive in the tri-snRNP but active in the pre-spliceosome. How is 
it regulated?
Several recent studies have delved into the details of Brr2 
regulation. In a series of papers from the Wahl lab70–74, Brr2 
structure and function were addressed by crystallography and 
biochemistry. The goal of Brr2 in the tri-snRNP is to maintain sta-
sis. As biochemistry experiments of Brr2 show64, there is a plug 
domain at the N-terminus of Brr2’s long N-terminal region (NTR). 
This plug folds back over the entrance of the helicase to block 
access of the U4/U6 snRNA duplex to the active site of Brr2. This 
is a unique intramolecular regulatory device, and more experiments 
are required to understand how it is directed to this position (and 
how it is displaced).
The tri-snRNP is an intermediate in the pathway to spliceosome 
formation. Years of enormous efforts to map intermediates42,63,75–77 
have now been coupled with technological advances in cryo- 
electron microscopy (cryo-EM) to visualize select transitional 
complexes70–72,78,79. Those efforts have produced a cryo-EM 
structure of human tri-snRNP that captures Brr2 in its plugged 
conformation72 (PDB ID 3jcr). This state of the tri-snRNP, illus-
trated in Figure 3, might represent its structure as an autonomous 
particle before it joins the pre-spliceosome, where U4 and U6 
snRNAs are still base-paired to each other. If so, then proteins and 
RNAs in the tri-snRNP must rearrange to present U4 and/or U6 
tails to the helicase active site.
In the tri-snRNP, Brr2 sits on the Jab1 domain of Prp8, but its ori-
entation and contacts change during activation of the particle. In 
contrast to the structure of the human tri-snRNP, in a structure of 
yeast tri-snRNP, a single-stranded region of U4 snRNA occupies 
the RNA-binding tunnel of Brr273,80,81 (illustrated in Figure 3). 
Is Brr2 now poised to completely separate U4 snRNA from 
U6 snRNA? Does this separation occur before the tri-snRNP is 
recruited to the pre-spliceosome, or is this a paused state that 
requires further activation?
There is another competitive inhibitor of Brr2. Prp8’s Jab1 domain 
has a C-terminal disordered tail that sneaks into the RNA tunnel 
of Brr2 to compete with U482. The intramolecular plug interaction 
and Prp8 Jab1 cooperate to inhibit unwinding. Removing the Jab1 
tail activates Brr2 helicase activity; Brr2 without its intramolecular 
plug also has enhanced activity75. Do both inhibitors operate in the 
isolated tri-snRNP?
Brr2 remains in the spliceosome after U4 snRNP has been expelled 
from the spliceosome. It is seen in a structure of yeast-activated 
spliceosome, which is defined by the loss of U1 and U4 snRNP 
and rearrangements of the remaining snRNAs to interact with each 
other and pre-mRNA. A cryo-EM structure of activated yeast spli-
ceosomes (Bact) shows Brr2 perched on Prp8’s Jab1 domain79, with 
its helicase activity blocked by both inhibitor interactions (PDB 
ID 5lqw). In an illustration from this structure, U2, U5, and U6 
snRNAs are remote from Brr2 (Figure 4). Although not clear from 
the perspective of Figure 4, Prp8 is entwined with other proteins 
and the snRNAs in this complex, even as it binds Brr2.
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Figure 3. Two tri-small nuclear ribonucleoprotein particle (snRNP) structures trap different states of Brr2. A. Human tri-snRNP 
cryo-electron microscopy (cryo-EM) at 7 Å resolution72 shows Brr2 sitting on Prp8 (PDB ID 3jcr). A U4/U6 snRNA duplex is visible. Sm and 
Lsm rings are pink; other proteins are white. B. In a yeast tri-snRNP complex70, (PDB ID 5GAN), U4 snRNA is threaded through Brr2 in the 
RNA-binding tunnel. These structures might correspond to the tri-snRNP in the nucleus (A) and the tri-snRNP poised for activation by Brr2 as 
it joins the pre-spliceosome (B). Visualized with visual molecular dynamics (VMD).
Figure 4. Yeast-activated (Bact) spliceosome79 (PDB ID 5LQW; cryo-electron microscopy [cryo-EM] 5.8Å). Brr2 has separated U4 and 
U6 small nuclear RNAs (snRNAs), and U4 small nuclear ribonucleoprotein particle (snRNP) has been expelled from the spliceosome. Brr2 
is bound to the Jab1 domain of Prp8. All 27 proteins are shown in surface representation; most are colored white. Visualized with visual 
molecular dynamics (VMD).
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As the spliceosome progresses through its cycle, there are many 
short RNA duplexes that need to be unwound. The other seven 
SF2 RNA helicases are recruited to the spliceosome when they are 
needed, and then they dissociate. Brr2 remains with the spliceo-
some until it has completed a splicing cycle, but there are no data 
suggesting that it is active at any time other than in the conversion 
from pre-spliceosome to Bact. If it is not required for its helicase 
activity, perhaps its long NTR contributes something to splicing. 
Brr2 is reported to contribute to catalysis74,83, to stabilize U5 and 
U6 in the spliceosome68, and to assist in the final disruption of the 
spliceosome and release of ligated exons84. If these states of the 
spliceosome could be trapped for structural studies, Brr2 might be 
captured in action.
The spliceosome is composed of hundreds of proteins56, many of 
which simply bind RNA, but others actively remodel it. In the past 
year, spliceosome structures have revealed connections between 
RNA and proteins that explain previous observations but also raise 
new questions. This year, structures of the spliceosome C/C* com-
plex show another helicase, prp16, at work on remodelling85–87. 
Slowly, this RNA enzyme is giving up its secrets.
Conclusions
There is a need to not only understand specific RNPs but 
also define general rules of engagement, since RNA–protein 
interactions dominate RNA biology. Indeed, the most mysterious are 
the membrane-less organelles that contain RNAs and proteins88,89. 
These conglomerates of RNAs bound by RNA-binding pro-
teins are variously thought to be centers of RNA processing, 
degradation, transcription, and exchange: P bodies and stress 
granules in the cytoplasm and nucleoli, Cajal bodies, speckles, 
and PML bodies in the nucleus. A current model is that disor-
dered domains of the proteins form a fluid matrix that allows a 
flux of molecules through these liquid droplets90,91. It is a sure bet 
that these droplets will be objects of intense scrutiny for years to 
come.
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